my sense is they will close the deal soon now. with the investor day out of the way and laying it out to investors that they will be spending low hundreds of millions "going forward". with the positive market reaction to the investor day and no challenge on the number they put forward they are not clear to close the deal.
p29 of investor day transcript CFO says "We expect to outlay around $450 million acquiring MedicalDirector and PowerHealth. We applied discretion applying MedicalDirector given its strategic significance to our Telstra Health portfolio. Going forward on M&A, we expect our insourcing of retail channels will cost in the low hundreds of millions."
so you could interpret this two ways - that the price for the whole in-sourcing project, or thats the price "going forward" i.e. for the remaining part of the retail outlets which is essentially Vita as they said for the FY21 results announcement that most of the others had been moped up.
VTG Price at posting:
88.0¢ Sentiment: Buy Disclosure: Held
